Send me a link:

*Text messaging rates may apply.

 Dow Down 0.42% Nasdaq Down 0.05%

Progenics Pharmaceuticals, Inc. (PGNX)

-NasdaqGS
5.03 Up 0.04(0.80%) 4:00PM EDT
|After Hours : 5.03 0.00 (0.00%) 4:31PM EDT
Prev Close:4.99
Open:5.00
Bid:4.80 x 1500
Ask:5.03 x 600
1y Target Est:9.50
Beta:1.7
Next Earnings Date:N/A
Day's Range:4.96 - 5.10
52wk Range:3.10 - 7.45
Volume:842,129
Avg Vol (3m):1,409,740
Market Cap:349.86M
P/E (ttm):N/A
EPS (ttm):-0.69
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PGNX

Comparison

Symbol% ChgMkt Cap
PGNXUp 0.80%349.86M
DNDNUp 0.48%325.73M
NKTRUp 0.82%1.40B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):46.58
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.20
Quarterly EPS Est (Jun-14) :-0.14
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-1.01

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Progenics Pharmaceuticals, Inc. develops medicines for oncology. The company offers Relistor-subcutaneous injection for the treatment of opioid induced constipation (OIC) in advanced-illness patients receiving palliative care when laxative therapy... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback